Kwon Y - Search Results

1

2,2-dimethyl-2H-pyran-derived alkaloids I. Practical synthesis of acronycine and benzo[b]acronycine and their biological properties.

Motiur Rahman AF, Liang JL, Lee SH, Son JK, Jung MJ, Kwon Y, Jahng Y. Motiur Rahman AF, et al. Among authors: kwon y. Arch Pharm Res. 2008 Sep;31(9):1087-93. doi: 10.1007/s12272-001-1273-7. Epub 2008 Sep 20. Arch Pharm Res. 2008. PMID: 18806949

2

Study on the synthesis and cytotoxicity of new quinophenoxazine derivatives.

Kwon Y, Na Y. Kwon Y, et al. Chem Pharm Bull (Tokyo). 2006 Feb;54(2):248-51. doi: 10.1248/cpb.54.248. Chem Pharm Bull (Tokyo). 2006. PMID: 16462076 Free article.

3

Synthesis of new xanthone analogues and their biological activity test--cytotoxicity, topoisomerase II inhibition, and DNA cross-linking study.

Woo S, Jung J, Lee C, Kwon Y, Na Y. Woo S, et al. Among authors: kwon y. Bioorg Med Chem Lett. 2007 Mar 1;17(5):1163-6. doi: 10.1016/j.bmcl.2006.12.030. Epub 2006 Dec 13. Bioorg Med Chem Lett. 2007. PMID: 17194586

4

New insight for fluoroquinophenoxazine derivatives as possibly new potent topoisomerase I inhibitor.

Kang DH, Kim JS, Jung MJ, Lee ES, Jahng Y, Kwon Y, Na Y. Kang DH, et al. Among authors: kwon y. Bioorg Med Chem Lett. 2008 Feb 15;18(4):1520-4. doi: 10.1016/j.bmcl.2007.12.053. Epub 2007 Dec 25. Bioorg Med Chem Lett. 2008. PMID: 18178085

5

Synthesis of isoquinolinone-based tetracycles as poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors.

Rhee HK, Lim SY, Jung MJ, Kwon Y, Kim MH, Choo HY. Rhee HK, et al. Among authors: kwon y. Bioorg Med Chem. 2009 Nov 1;17(21):7537-41. doi: 10.1016/j.bmc.2009.09.014. Epub 2009 Sep 15. Bioorg Med Chem. 2009. PMID: 19800803

6

Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.

Cho HJ, Jung MJ, Kwon Y, Na Y. Cho HJ, et al. Among authors: kwon y. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6766-9. doi: 10.1016/j.bmcl.2009.09.091. Epub 2009 Sep 27. Bioorg Med Chem Lett. 2009. PMID: 19836231

7

2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.

Thapa P, Karki R, Thapa U, Jahng Y, Jung MJ, Nam JM, Na Y, Kwon Y, Lee ES. Thapa P, et al. Among authors: kwon y. Bioorg Med Chem. 2010 Jan 1;18(1):377-86. doi: 10.1016/j.bmc.2009.10.049. Epub 2009 Oct 29. Bioorg Med Chem. 2010. PMID: 19939682

8

2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study.

Basnet A, Thapa P, Karki R, Choi H, Choi JH, Yun M, Jeong BS, Jahng Y, Na Y, Cho WJ, Kwon Y, Lee CS, Lee ES. Basnet A, et al. Among authors: kwon y. Bioorg Med Chem Lett. 2010 Jan 1;20(1):42-7. doi: 10.1016/j.bmcl.2009.11.041. Epub 2009 Nov 14. Bioorg Med Chem Lett. 2010. PMID: 19954977

9

New benzoxanthone derivatives as topoisomerase inhibitors and DNA cross-linkers.

Cho HJ, Jung MJ, Woo S, Kim J, Lee ES, Kwon Y, Na Y. Cho HJ, et al. Among authors: kwon y. Bioorg Med Chem. 2010 Feb;18(3):1010-7. doi: 10.1016/j.bmc.2009.12.069. Epub 2010 Jan 4. Bioorg Med Chem. 2010. PMID: 20093033

10

Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.

Thapa P, Karki R, Choi H, Choi JH, Yun M, Jeong BS, Jung MJ, Nam JM, Na Y, Cho WJ, Kwon Y, Lee ES. Thapa P, et al. Among authors: kwon y. Bioorg Med Chem. 2010 Mar 15;18(6):2245-2254. doi: 10.1016/j.bmc.2010.01.065. Epub 2010 Feb 4. Bioorg Med Chem. 2010. PMID: 20188578

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,249 results

Search Page

Filters